Consensus Sanofi

Equities

Market Closed - Euronext Paris Other stock markets 11:39:46 2024-12-10 am EST			Pre-market 01:34:55 am
91.75 ^EUR	-0.08%		91.90	+0.16%

07:33am	Sanofi Secures Fast-track Designation in US for Two Combination Vaccines for Influenza, COVID-19	MT
Dec. 10	SANOFI : Jefferies reiterates its Buy rating	ZD

ee148dd996b1.KyM8Q6DeCLPjs5G9a4ZT3vjYwhCjrXB3oeq8uJQT4ng.Bk11J_aIcoOk4vvZP8Rin6Czi2nkwgok662M_sV0jEtgTWM0woFN8q3e8g~90b7da5545b3228af6f4f30e9ad6c60f

SANOFI : Jefferies reiterates its Buy rating	Dec. 10	ZD
SANOFI : Gets a Sell rating from Deutsche Bank	Dec. 06	ZD
SANOFI : Deutsche Bank maintains a Sell rating	Dec. 03	ZD
SANOFI : JP Morgan sticks Neutral	Dec. 03	ZD
Intron Health Downgrades Sanofi to Hold, Lowers PT	Nov. 29	MT
CIC Market Solutions Upgrades Sanofi to Buy	Nov. 22	MT
AlphaValue/Baader Europe Upgrades Sanofi to Buy, Trims PT	Nov. 21	MT
SANOFI : UBS reiterates its buy recommendation	Oct. 29	CF
SANOFI : Deutsche Bank gives a Sell rating	Oct. 28	ZD
SANOFI : Gets a Neutral rating from DZ Bank	Oct. 28	ZD
SANOFI : UBS keeps its Buy rating	Oct. 28	ZD
SANOFI : Q3 beat; all eyes now on the innovative pharma business promises	Oct. 25
SANOFI : UBS maintains a Buy rating	Oct. 25	ZD
SANOFI : JP Morgan reiterates its Neutral rating	Oct. 25	ZD
SANOFI : Jefferies reaffirms its Buy rating	Oct. 25	ZD
SANOFI : Receives a Buy rating from UBS	Oct. 21	ZD
SANOFI : JP Morgan reaffirms its Neutral rating	Oct. 21	ZD
SANOFI : Receives a Buy rating from Jefferies	Oct. 21	ZD
SANOFI : Oddo BHF remains positive after Opella announcement	Oct. 21	CF
SANOFI : Receives a Buy rating from UBS	Oct. 18	ZD
SANOFI : JP Morgan reaffirms its Neutral rating	Oct. 18	ZD
SANOFI : Berenberg maintains a Buy rating	Oct. 18	ZD
SANOFI : JP Morgan gives a Neutral rating	Oct. 17	ZD
SANOFI : UBS reaffirms its Buy rating	Oct. 17	ZD
SANOFI : Deutsche Bank remains a Sell rating	Oct. 16	ZD

	Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Analyst Opinion	4m Revision of opinion	Divergence of analysts' opinions	Divergence of Target Price	Ecart obj. / dr
	SANOFI					+24.25%
	ELI LILLY AND COMPANY					+22.93%
	NOVO NORDISK A/S					+19.89%
	JOHNSON & JOHNSON					+16.90%
	ABBVIE INC.					+14.59%
	MERCK & CO., INC.					+25.57%
	ROCHE HOLDING AG					+17.95%
	ASTRAZENECA PLC					+29.36%
	NOVARTIS AG					+13.54%
	AMGEN INC.					+18.28%
	Average					+20.33%
	Weighted average by Cap.					+20.37%

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

91.75EUR

Average target price

114.09EUR

Spread / Average Target

+24.35%

High Price Target

126.00EUR

Spread / Highest target

+37.33%

Low Price Target

85.00EUR

Spread / Lowest Target

-7.36%